ribociclib

Ukraine

Drugs containing this active substance

  • KISCALI

    The drug is prescribed for the treatment of women with early-stage breast cancer (in combination with an aromatase inhibitor), as well as for the treatment of women with locally advanced or metastatic breast cancer (in combination with an aromatase inhibitor or fulvestrant).

    Form: tablets, film-coated

    Active substance Dosage
    ribociclib 200 mg

    ATC: L01EF02

    Manufacturer: Novartis Pharmaceutical Manufacturing LLC (manufacturing, primary and secondary packaging, partial quality control, batch release)